HHS files, then drops, its data-tracking lawsuit appeal

In less than 24 hours this week, the U.S. Department of Health and Human Services filed an appeal in American Hospital Association v. Becerra – a lawsuit that sought to bar enforcement of an Office for Civil Rights rule governing use of online tracking tools – and then promptly withdrew it.

The American Hospital Association, which has sought to protect its members’ ability to use the tracking tools, issued a statement Thursday in which Chad Golder, AHA’s general counsel, called the result a “victory.”

WHY IT MATTERS

While HHS had appealed the Fort Worth, Texas federal court’s June ruling, it quickly withdrew the appeal, without saying why.

“The HHS Office for Civil Rights has no comment on litigation,” a spokesperson for the agency said by email on Thursday.

The OCR rule, “Use of Online Tracking Technologies by HIPAA Covered Entities and Business Associates,” aimed to protect patient privacy by limiting the scope of tracking pixel use. 

But the Texas court blocked the agency’s ability to prohibit hospital websites from using consumer-tracking technology under HIPAA and the Federal Trade Commission’s Health Breach Notification Rule, issued in a December 2022 guidance on use of the tools

The American Hospital Association has long argued that HIPAA-covered entities need to use online tracking pixels on websites and mobile apps, and that OCR’s attempt to curtail the use of third-party web technologies that capture IP addresses on public webpages was both “unlawful and unwise.”

THE LARGER TREND

In the original complaint the AHA filed in federal court, the hospital group said enforcement of OCR’s regulations on pixel-tracking tools would disrupt the “balance that HIPAA and its regulations strike between privacy and information-sharing.”

“The HHS rule exceeds the government’s statutory and constitutional authority, fails to satisfy the requirements for agency rulemaking and harms the very people it purports to protect,” the AHA said when it filed the lawsuit in November.

While Advocate Aurora Health paid more than $12.2 million to settle a class-action suit over a pixel-related privacy breach in October 2022, legal advisors contended that there were safe ways for health systems and hospitals to manage pixel tracking as the case played out in court. 

Joined by the Texas Hospital Association, Texas Health Resources and United Regional Health Care System, the hospital group sued HHS. Seventeen state hospital associations and 30 hospitals and health systems filed friend-of-the-court briefs supporting AHA and its coplaintiffs in the lawsuit, according to AHA statement.

ON THE RECORD

“As the AHA repeatedly explained to OCR – both before and after OCR forced the AHA to file its lawsuit – this rule was a gross overreach by the federal government, imposed without any input from healthcare providers or the general public,” Golder said in the statement just hours after HHS filed and then dropped the appeal.

“Now that the Bulletin’s illegal rule has been vacated once and for all, hospitals can safely share reliable, accurate health care information with the communities they serve without the fear of federal civil and criminal penalties.”

Andrea Fox is senior editor of Healthcare IT News.
Email: afox@himss.org

Healthcare IT News is a HIMSS Media publication.

Note: This article have been indexed to our site. We do not claim legitimacy, ownership or copyright of any of the content above. To see the article at original source Click Here

Related Posts
The Power of prebiotics & probiotics thumbnail

The Power of prebiotics & probiotics

Probiotics and prebiotics are essential components of a healthy diet, offering a range of health benefits that extend far beyond good digestion. Probiotics are live microorganisms that, when consumed in adequate amounts, provide numerous health effects, including improved gut health, enhanced immune function and mental health, and relief from digestive disorders. Prebiotics, on the other
Read More
Aromatase inhibitors better than tamoxifen at reducing the risk of breast cancer recurrence in women thumbnail

Aromatase inhibitors better than tamoxifen at reducing the risk of breast cancer recurrence in women

Credit: Unsplash/CC0 Public Domain A new study has shown that giving aromatase inhibitors instead of tamoxifen to premenopausal women with estrogen receptor positive (hormone-sensitive) breast cancer significantly reduces the risk of breast cancer recurrence. The results have been published today in The Lancet Oncology. For women with hormone-sensitive, operable breast cancer, giving tamoxifen treatment after…
Read More
Global taskforce of scientists develop a unifying framework for the 'Human Affectome' thumbnail

Global taskforce of scientists develop a unifying framework for the ‘Human Affectome’

The Human Affectome. Credit: Mount Sinai Health System To improve upon current scientific understanding of how our feelings, emotions, and moods relate to and impact human behavior—known in the field as "affective science"—an interdisciplinary task force of 173 scientists from 23 countries, has created an integrative framework that encompasses the enormous array of affective phenomena
Read More
Predicting Early Mortality in Alcohol-Associated Hepatitis thumbnail

Predicting Early Mortality in Alcohol-Associated Hepatitis

A novel scoring system proved accurate for predicting which patients with alcohol-associated hepatitis are at high risk of short-term mortality, according to researchers. In a derivation cohort, the so-called Mortality Index for Alcohol-Associated Hepatitis (MIAAH) model -- which incorporates patients' age, blood urea nitrogen, albumin, bilirubin, and international normalized ratio (INR) -- achieved a C…
Read More
Ethiopia launches the Pandemic Fund mega project against potential pandemics thumbnail

Ethiopia launches the Pandemic Fund mega project against potential pandemics

Addis Ababa, Ethiopia.  In a remarkable move towards strengthening its defenses against potential pandemics, Ethiopia officially launched the Ethiopian Pandemic Multi-Sectoral Prevention, Preparedness, and Response Project (EPPR) on Monday, January 29, 2024.  Held in Addis Ababa, Ethiopia, the project launch was attended by H.E. Dr. Lia Tadesse, Minister of Health, H.E. Dr. Girma Amente, Minister of
Read More
Index Of News